Advancing Global Health Equity in Oncology Clinical Trial Access.

IF 29.7 1区医学 Q1 ONCOLOGY

Cancer discovery Pub Date : 2024-09-24 DOI:10.1158/2159-8290.CD-24-1288

引用次数: 0

Abstract

Despite exponentially increased industry investment in oncology research and development with more than $80 billion spent annually, patient enrollment in clinical trials remains below 5% globally. Our multistakeholder international cancer coalition envisions ecosystem transformation with capacity building through a global "hub-and-spoke" network model to expand access to and accelerate clinical trials, thus ending cancer as a major cause of death in this lifetime.

查看原文本刊更多论文

在肿瘤学临床试验中促进全球健康公平。

尽管业界对肿瘤研发的投资呈指数级增长，每年投入超过 800 亿美元，但全球临床试验的患者注册率仍低于 5%。我们的多方利益相关者国际癌症联盟设想通过全球 "枢纽-辐条 "网络模式进行能力建设，实现生态系统转型，以扩大临床试验的可及性并加快临床试验的进程，从而终结癌症这一主要致死原因。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer discovery ONCOLOGY-

CiteScore

22.90

自引率

1.40%

发文量

838

审稿时长

6-12 weeks

期刊介绍： Cancer Discovery publishes high-impact, peer-reviewed articles detailing significant advances in both research and clinical trials. Serving as a premier cancer information resource, the journal also features Review Articles, Perspectives, Commentaries, News stories, and Research Watch summaries to keep readers abreast of the latest findings in the field. Covering a wide range of topics, from laboratory research to clinical trials and epidemiologic studies, Cancer Discovery spans the entire spectrum of cancer research and medicine.